We are Hiring! JVPLabs is seeking a Mechanical Engineer to assist the development of our home monitoring technology for CHF. This mechanical engineering job is located in the beautiful, rugged and Covid-free St. John's, NL! Memorial Centre for Entrepreneurship (MCE) Bounce Health Innovation techNL #MedTech #reboottherock

This is a gooooood idea.

The mocha632 news is incredible for the local startup ecosystem. “Exits” like this one tend to stimulate startup creation and investments in the associated ecosystem! There has never been a better time to create or grow a startup in the St. John's startup ecosystem!

Very proud of the contribution of my wife to the province of Newfoundland and Labrador. 😍 It’s hard to imagine that we have been here for almost five years. We fell in love with the nature of the province, the kindness of its people and what it could become.

This is such a big deal! An NL company innovating to provide a locally manufactured, Health Canada approved swab just when our province needs it most. Bravo Christine Goudie & GranvilleBiomedical team!

Today we're releasing a report outlining options for an equitable, people & community-centred economic recovery. The report was developed over 5 months with input from more than 60 academics, community organizers, activists & organizations #NLPoli bit.ly/3hBbkCi

.BreatheSuite is excited to announce we have received 510(K) clearance from the U.S. FDA for our BreatheSuite Metered-Dose Inhaler (MDI) V1 device, which monitors and provides feedback on inhaler adherence and technique for people with #asthma and #COPD. bit.ly/39H2uxy

Join us for an ECHO Lessons from Leaders webinar featuring Dr. Andrew J Smith (Andrew Smith), CSO & Co-Founder at JVPLabs. Register in advance for this webinar: us02web.zoom.us/meeting/regist… #entrepreneurs #innovative #healthtechnology #startups

Our next #IMIE2022 company highlight is JVPLabs! JVPLabs is developing and will commercialize a unique system for management of Congestive Heart Failure (CHF) patients. Pictured here is JVPLabs’ Stacey Chaulk (left), and #MUNBusiness intern Riley Wilson (right).

Inspiring and hopeful clinical case out of England - and the first human clinical proof of concept for base editing!! bbc.com/news/health-63…

Ground-breaking gene-editing treatment leaves patient feeling like they have 'a new body' $NTLA #CRISPR $XBI #GeneEditing “Rose said the eight months since her infusion had been incredible.” rnz.co.nz/news/national/…

Congrats to sentiar on closing a Series B round of financing! The future is so bright! Jon Silva Berk Michael Southworth WashU Pediatric Cardiology WashU Biomedical Engineering WashU Tech Transfer prnewswire.com/news-releases/…

Last data for $rlay prior to #AACR2023 Was posted March 9. Many patients were perceived to be close to a demonstrated response. It is felt that PI3K needs time to be proven effective. Are the doses weekly? How often are doses increased?

I know all the lyrics to “The Wreck of the Edmund Fitzgerald” and I bet Michael Gilman does too. Gordon Lightfoot RIP.

Wow. The Los Angeles Dodgers have re-signed Outfielder Andrew Toles who has schizophrenia and hasn’t played since 2018, so he would still have access to the team’s health insurance and mental health services. Toles is not expected to play for the Dodgers this season and will

$pdsb Wondering what are the FDA criteria to get emergency access to a investigational treatment? Just curious if this is an option particularly for patients in the refractory group that don’t have other options?

Just made up an awful Dad joke: Why are there so many Tesla’s off the coast of Africa? Because they’re Mad at Gas Car

PDS Biotechnology The next update from PDS Biotechnology needs to be Frank departing from the company. It would be welcomed more than funding/partnership news at this point.

President Zelensky is a warrior. Trump and Vance are 2 cowards beholden to Putin. Such an utter geopolitical disgrace for America.

$verv Is there any clarity regarding the timing of the acquisition, when we get the promissory note, and capital gets returned to investors?